298 related articles for article (PubMed ID: 15095235)
1. Failure of low-dose atovaquone prophylaxis against Pneumocystis jiroveci infection in transplant recipients.
Rodriguez M; Sifri CD; Fishman JA
Clin Infect Dis; 2004 Apr; 38(8):e76-8. PubMed ID: 15095235
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole-intolerant orthotopic liver transplant patients: a preliminary study.
Meyers B; Borrego F; Papanicolaou G
Liver Transpl; 2001 Aug; 7(8):750-1. PubMed ID: 11510024
[TBL] [Abstract][Full Text] [Related]
3. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
[TBL] [Abstract][Full Text] [Related]
4. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
[TBL] [Abstract][Full Text] [Related]
5. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
[TBL] [Abstract][Full Text] [Related]
6. Reinstituting trimethoprim--sulfamethoxazole in patients receiving atovaquone for Pneumocystis carinii pneumonia prophylaxis.
James CW; McNelis KC; Szabo S
Am J Health Syst Pharm; 2003 Aug; 60(15):1572-4. PubMed ID: 12951757
[No Abstract] [Full Text] [Related]
7. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
[TBL] [Abstract][Full Text] [Related]
8. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.
Hughes W; Leoung G; Kramer F; Bozzette SA; Safrin S; Frame P; Clumeck N; Masur H; Lancaster D; Chan C
N Engl J Med; 1993 May; 328(21):1521-7. PubMed ID: 8479489
[TBL] [Abstract][Full Text] [Related]
9. Prevention of infection due to Pneumocystis carinii.
Fishman JA
Antimicrob Agents Chemother; 1998 May; 42(5):995-1004. PubMed ID: 9593116
[No Abstract] [Full Text] [Related]
10. Switch to atovaquone and subsequent re-challenge with trimethoprim-sulfamethoxazole for Pneumocystis prophylaxis in a kidney transplant population.
McLaughlin MM; Galal A; Richardson CL; Sutton SH; Barr VO; Patel N; Mitchell P; Stosor V
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28833985
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis and therapy for Pneumocystis pneumonia--where are we?
Masur H
Infect Agents Dis; 1992 Oct; 1(5):270-8. PubMed ID: 1344666
[TBL] [Abstract][Full Text] [Related]
12. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
Diri R; Anwer F; Yeager A; Krishnadasan R; McBride A
Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
[TBL] [Abstract][Full Text] [Related]
13. Atovaquone as prophylaxis against Pneumocystis carinii pneumonia.
Fisher MJ; Gazzard BG; Hawkins DA; Nelson MR
J Infect; 1994 Jan; 28(1):103-4. PubMed ID: 8163822
[No Abstract] [Full Text] [Related]
14. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Castro M
Semin Respir Infect; 1998 Dec; 13(4):296-303. PubMed ID: 9872626
[TBL] [Abstract][Full Text] [Related]
15. Pneumocystis carinii pneumonia prophylaxis: current therapies and recommendations.
Crozier F
J Pediatr Oncol Nurs; 2011; 28(3):179-84. PubMed ID: 21636828
[TBL] [Abstract][Full Text] [Related]
16. Inhaled pentamidine for Pneumocystis jiroveci prophylaxis in a heart transplant recipient with allergy for trimethoprim sulfamethoxazole.
Altintas G; Diken AI; Diken OE; Hanedan O; Kucuker SA
Exp Clin Transplant; 2011 Feb; 9(1):72-3. PubMed ID: 21605028
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the activities of rifabutin combined with atovaquone or low-dose of cotrimoxazole for prevention of pneumocystosis and toxoplasmosis in a dual infection rat model.
Brun-Pascaud M; Chau F; Rajagopalan-Levasseur P; Derouin F; Girard PM
J Eukaryot Microbiol; 1996; 43(5):14S-15S. PubMed ID: 8822822
[No Abstract] [Full Text] [Related]
18. Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia.
Madden RM; Pui CH; Hughes WT; Flynn PM; Leung W
Cancer; 2007 Apr; 109(8):1654-8. PubMed ID: 17345613
[TBL] [Abstract][Full Text] [Related]
19. Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation.
Gabardi S; Millen P; Hurwitz S; Martin S; Roberts K; Chandraker A
Clin Transplant; 2012; 26(3):E184-90. PubMed ID: 22487221
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis Cytochrome b Mutants Associated With Atovaquone Prophylaxis Failure as the Cause of Pneumocystis Infection Outbreak Among Heart Transplant Recipients.
Argy N; Le Gal S; Coppée R; Song Z; Vindrios W; Massias L; Kao WC; Hunte C; Yazdanpanah Y; Lucet JC; Houzé S; Clain J; Nevez G
Clin Infect Dis; 2018 Aug; 67(6):913-919. PubMed ID: 29514207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
